Literature DB >> 3550501

Endotoxemia in chronic renal failure.

U Nisbeth, R Hällgren, O Eriksson, B G Danielson.   

Abstract

In the past years dialyzers have been improved, and consequently pyrogenic reactions have become rare. However, some patients in our dialysis unit have shown symptoms during hemodialysis which we suspected could be caused by endotoxins. These patients, as well as controls without similar symptoms, had elevated levels of circulating endotoxin. We therefore measured endotoxin in blood from patients with chronic renal failure and different kinds of treatment. Serum samples were analyzed with a sensitive method described in the literature, using a chromogenic substrate and Limulus amebocyte lysate. In patients on hemodialysis (mean +/- SEM) the endotoxin value in samples taken immediately before dialysis was 40 +/- 4.7 ng/l and significantly elevated (p less than 0.001) compared with the endotoxin value (7 +/- 0.6 ng/l) found in the healthy reference group. Increased endotoxin levels were also seen in patients on hemofiltration (19 +/- 7.5 ng/l) and in patients with conservative treatment and various degrees of renal insufficiency (17 +/- 2.5 ng/l). Patients on peritoneal dialysis and renal-transplanted patients had levels not different from the controls. The mechanism behind endotoxemia in uremia is unknown but may partly be explained by reduced endotoxin elimination due to impaired liver macrophage function. The differences in endotoxin levels in patients on peritoneal or hemodialysis treatment may reflect that extracorporeal circulation enhances endotoxin entrance to the circulation and/or that endotoxin clearance is dependent on the dialysis regimen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3550501     DOI: 10.1159/000184086

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  11 in total

1.  Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Christopher W McIntyre; Laura E A Harrison; M Tarek Eldehni; Helen J Jefferies; Cheuk-Chun Szeto; Stephen G John; Mhairi K Sigrist; James O Burton; Daljit Hothi; Shvan Korsheed; Paul J Owen; Ka-Bik Lai; Philip K T Li
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

2.  Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Authors:  Ruben Poesen; Ali Ramezani; Kathleen Claes; Patrick Augustijns; Dirk Kuypers; Ian R Barrows; Jagadeesan Muralidharan; Pieter Evenepoel; Björn Meijers; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 8.237

3.  The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease.

Authors:  Stephen G John; Paul J Owen; Laura E A Harrison; Cheuk-Chun Szeto; Ka-Bik Lai; Philip K T Li; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

4.  Cytokines induce stress protein formation in cultured cardiac myocytes.

Authors:  I Löw-Friedrich; D Weisensee; P Mitrou; W Schoeppe
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

5.  Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

Authors:  Dominic S C Raj; Juan J Carrero; Vallabh O Shah; Abdul R Qureshi; Peter Bárány; Olof Heimbürger; Bengt Lindholm; Jennet Ferguson; Pope L Moseley; Peter Stenvinkel
Journal:  Am J Kidney Dis       Date:  2009-09-06       Impact factor: 8.860

6.  Endotoxin levels in sera of elderly individuals.

Authors:  T Goto; S Edén; G Nordenstam; V Sundh; C Svanborg-Edén; I Mattsby-Baltzer
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

7.  Vitamin D3 repletion in chronic kidney disease stage 3: effects on blood endotoxin activity, inflammatory cytokines, and intestinal permeability.

Authors:  Manish P Ponda; Jan L Breslow
Journal:  Ren Fail       Date:  2013-03-18       Impact factor: 2.606

8.  Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients.

Authors:  Cheuk-Chun Szeto; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Ka-Bik Lai; Kwok-Yi Chung; Chi-Bon Leung; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 8.237

9.  Candida Administration in Bilateral Nephrectomy Mice Elevates Serum (1→3)-β-D-glucan That Enhances Systemic Inflammation Through Energy Augmentation in Macrophages.

Authors:  Jiraphorn Issara-Amphorn; Cong Phi Dang; Wilasinee Saisorn; Kavee Limbutara; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

Review 10.  Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.

Authors:  D S March; M P M Graham-Brown; C M Stover; N C Bishop; J O Burton
Journal:  Biomed Res Int       Date:  2017-01-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.